RELX (RELX) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

RELX (RELX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Investment Research • May 14, 2026

RELX PLC (RELX) Discusses Business Services Strategy and Innovation in Fraud and Identity Solutions Transcript

RELX PLC (RELX) Discusses Business Services Strategy and Innovation in Fraud and Identity Solutions Transcript

Seeking Alpha • May 13, 2026

RELX: Time To Get In (Rating Upgrade)

RELX (RELX) is now rated a 'BUY' with a new ADR price target of $33.8, reflecting improved valuation and resilient fundamentals. RELX's data and workflow solutions, especially Lexis+, maintain a strong moat against generative AI disruption, supporting stable growth and margin expansion. Organic growth remains robust at 6-7%, with dividend yield above 2.75% and operating leverage from AI-driven efficiencies.

Seeking Alpha • May 13, 2026

Consumers Ready and Comfortable to Share their Medical Information Electronically for Easier Life Insurance Underwriting

LexisNexis®  Life Insurance Consumer Experience Study Explores Pain Points and Potential Ways to Improve the Life Insurance Application Process ATLANTA, May 7, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions today announced findings from a new consumer research study examining attitudes and perceptions about the life insurance application process, as the industry looks for ways to deliver faster life insurance underwriting and reduce life insurance application dropout rates. The research asked life insurance applicants about the effort involved and the time it takes to complete an application, offering updated insight into where the process creates challenges that can leave applicants less satisfied and, in some cases lead them to abandon the process entirely.

PRNewsWire • May 7, 2026

Artisan Global Opportunities Fund Q1 2026 Portfolio Activity

During the quarter, we initiated new positions in Edwards Lifesciences, Eli Lilly and Roblox. In addition to Linde, Shopify and Amazon, we also added to Woodward and Spotify during the quarter. We ended our investment campaigns in Netflix, Snowflake and RELX during the quarter.

Seeking Alpha • Apr 29, 2026

RELX Group enters into agreement to acquire French Legaltech company Doctrine

RELX Group is planning to acquire Doctrine, strengthening authoritative legal AI workflows in France and across Europe. RELX Group is planning to acquire Doctrine, strengthening authoritative legal AI workflows in France and across Europe.

GlobeNewsWire • Apr 28, 2026

RELX: Thriving During The 'SaaSpocalypse'

RELX (RELX) is rated a buy, with strong growth, high profitability, and a more reasonable valuation post-‘SaaSpocalypse' AI fears. RELX's legal and risk segments are well-protected by proprietary data, limiting AI disruption risk and supporting robust earnings growth guidance. Trading at a 20x forward P/E, RELX is fairly valued, with expected high single-digit EPS growth and a 2.5% progressive dividend yield.

Seeking Alpha • Apr 24, 2026

RELX shares fall as upbeat trading update fails to lift sentiment

Shares in FTSE 100 giant RELX PLC (LSE:REL) fell 2.7% to 2,664p despite the information and analytics group reporting a strong start to 2026 and reaffirming its full-year outlook. In a statement ahead of its annual meeting, the group pointed to positive momentum across all four divisions and said it continues to invest in artificial intelligence, combining large proprietary data sets with new technologies to launch products and drive usage.

Proactive Investors • Apr 23, 2026

Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers

The collaboration accelerates digital risk processing by integrating comprehensive data and analytics directly into AI-enabled digital underwriting workflows ATLANTA, April 23, 2026 /PRNewswire/ -- Cytora and LexisNexis® Risk Solutions have announced a strategic relationship to embed best-in-class data and advanced analytics from LexisNexis Risk Solutions directly into the Cytora platform to help U.S. commercial insurance companies scale their ability to assess, predict and manage risk. For U.S. commercial insurers, a centralized and automated approach to underwriting can help deliver unparalleled insight into risk selection.

PRNewsWire • Apr 23, 2026

LexisNexis Risk Solutions Builds on Agenium Alliance with Expanded Medical Data Access for Life Insurers

Integration of LexisNexis Health Intelligence platform with Agenium's no-code SaaS platform can help life insurers adopt EHRs at scale and enable straight-through processing ATLANTA and AUSTIN, Texas, April 16, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions has announced at the Association of Home Office Underwriters (AHOU) 2026 annual conference the integration of its digital health data platform, LexisNexis® Health Intelligence, with Agenium's modern, no code configurable platform, building on the companies' existing alliance. This latest integration makes it easier for life insurers to access medical records and related insights, such as electronic health records (EHRs) and sets the stage for carriers to receive decision-grade curated medical insights from LexisNexis Risk Solutions, reflecting the company's commitment to advancing intelligence for risk decisions and more efficient digital workflows.

PRNewsWire • Apr 16, 2026